Unraveling the Mystery of Cancer: A Journey through Basics and Advancements

Understanding Cancer Markers: Unveiling the Promise and Limitations

Hyperbaric Oxygen Therapy and Cancer Treatment

The relationship between cancer and oxygen is complicated, and nothing written here is going to change that. However, an alternative treatment option sometimes revolves around the use of hyperbaric chambers and ‘oxygen-loading’ programs, and as a matter of due diligence we should dive into the scientific merit here.

Side Effects of Immunotherapy vs. Chemotherapy: A Comparative Analysis

Cancer treatment has witnessed significant advancements over the years, with a multitude of therapeutic options now available to patients. Among these, chemotherapy and immunotherapy have emerged as two primary modalities.

Benefits of Immunotherapy at Every Stage of Cancer

In the world of cancer treatment, time is a critical factor. The sooner the intervention, the better the outcomes. This is particularly true for immunotherapy, a groundbreaking treatment strategy that leverages the body’s immune system to combat cancer.

Triumph Over Stage 4 Melanoma: Brock’s Inspiring Journey

Brock S. had his world turned upside down when he was diagnosed with Stage 4 Melanoma in July 2022. With his cancer growing by 300% within five months since the initial diagnosis, he was given roughly three months to live.

Now six months after completing treatment and with remission in sight, Brock recently visited Immunocine to share his story.

Shining the Light on Vitamin D and Cancer Treatment

Worryingly, about 35-45% of Americans don’t have enough Vitamin D11, the essential nutrient that our bodies need for tasks like absorbing calcium in the gut and maintaining healthy bones^{2, 3.}

Babette’s Cancer Journey: Remarkable Progress and a Future in Sight

Babette’s journey with Immunocine is progressing steadily, and we’re excited to bring you another update on her path to recovery. Now nearly five months after completing her treatment, Babette continues to work with the Immunocine Team, who evaluate her medical reports and scans to closely to provide feedback.

Immunocine Dendritic Cell Therapy for Colorectal Cancers

Colorectal cancers have been on the rise and now afflict more than 2 million humans per year, more than 150,000 Americans per year¹, and is simultaneously becoming one of the deadliest cancer categories across genders^{2, 3}.

Dendritic Cells and Their Therapeutic Role in Prostate Cancer

In 2022, almost 270,000 American men will be diagnosed with prostate cancer, and about 35,000 prostate cancer patients will succumb to the disease.